Second, in ischemic stroke models, ERK1/2 signaling is known to exhibit temporally distinct roles—early neuroprotective activation (<72 h) versus late pathological hyperactivity (7+ days) [29]. This evidence concerns the gene MAPK3 and ischemic stroke.